These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25047363)

  • 61. Is TAVR Ready for the Global Aging Population?
    Bergmann T; Sengupta PP; Narula J
    Glob Heart; 2017 Dec; 12(4):291-299. PubMed ID: 28433492
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of Neighborhood Social Deprivation on Delays to Access for Transcatheter Aortic Valve Replacement: Wait-Times and Clinical Consequences.
    Zaheer A; Qiu F; Manoragavan R; Madan M; Sud M; Mamas MA; Wijeysundera HC
    J Am Heart Assoc; 2024 Jun; 13(12):e032450. PubMed ID: 38879459
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Paravalvular aortic regurgitation after transcatheter aortic valve replacement].
    Buğan B; Tuzcu EM
    Turk Kardiyol Dern Ars; 2014 Jan; 42(1):83-93. PubMed ID: 24481103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transcatheter aortic valve replacement (TAVR) in patients with systemic autoimmune diseases.
    Fuentes-Alexandro S; Escarcega R; Garcia-Carrasco M; Cervera R
    Lupus; 2013 Nov; 22(13):1433-4. PubMed ID: 24003080
    [No Abstract]   [Full Text] [Related]  

  • 65. The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement.
    Ribera A; Slof J; Ferreira-González I; Serra V; García-Del Blanco B; Cascant P; Andrea R; Falces C; Gutiérrez E; Del Valle-Fernández R; Morís-de laTassa C; Mota P; Oteo JF; Tornos P; García-Dorado D
    Eur J Health Econ; 2018 Sep; 19(7):945-956. PubMed ID: 29170843
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factor VIIa for Annulus Rupture After Transcatheter Aortic Valve Replacement.
    Keenan JE; Vavalle JP; Ganapathi AM; Wang H; Harrison JK; Wang A; Hughes GC
    Ann Thorac Surg; 2015 Jul; 100(1):313-5. PubMed ID: 26140778
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk Assessment in Patient Selection for Transcatheter Aortic Valve Replacement.
    Walsh JA; Teirstein PS; Stinis C; Price MJ
    Interv Cardiol Clin; 2015 Jan; 4(1):1-12. PubMed ID: 28582117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conventional aortic valve replacement: still a feasible option in the transcatheter aortic valve implantations era?
    Cremer J
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1253-4. PubMed ID: 22398464
    [No Abstract]   [Full Text] [Related]  

  • 69. Cardiac tamponade after transcatheter aortic valve replacement using a transaortic approach.
    Wang C; Hamburger J; Bhatt H
    A A Case Rep; 2014 Nov; 3(9):113-5. PubMed ID: 25611860
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement.
    Marchini JF; Miyakawa AA; Tarasoutchi F; Krieger JE; Lemos P; Croce K
    J Negat Results Biomed; 2016 Apr; 15():7. PubMed ID: 27063005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transcatheter Aortic Valve Replacement in Moderate-risk Aortic Stenosis Patients.
    Svensson LG
    Interv Cardiol; 2014 Mar; 9(1):41-43. PubMed ID: 29588777
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Conventional AVR and TAVR in patients with autoimmune disease.
    Keeling IM; Maier RM; Dapunt OE
    Lupus; 2015 Jan; 24(1):107-8. PubMed ID: 25193330
    [No Abstract]   [Full Text] [Related]  

  • 73. Complementary Role of the Computed Biomodelling through Finite Element Analysis and Computed Tomography for Diagnosis of Transcatheter Heart Valve Thrombosis.
    Nappi F; Mazzocchi L; Avtaar Singh SS; Morganti S; Sablayrolles JL; Acar C; Auricchio F
    Biomed Res Int; 2018; 2018():1346308. PubMed ID: 30426001
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recurrent Balloon Rupture During Transcatheter Aortic Valve Replacement (TAVR) - Implication for Access Site Choice.
    Mustafa A; Farooq V; Manoly I; Hassan R; Fraser DG
    Heart Lung Circ; 2015 Nov; 24(11):e193-4. PubMed ID: 26150006
    [No Abstract]   [Full Text] [Related]  

  • 75. Aortic stenosis post-COVID-19: a mathematical model on waiting lists and mortality.
    Stickels CP; Nadarajah R; Gale CP; Jiang H; Sharkey KJ; Gibbison B; Holliman N; Lombardo S; Schewe L; Sommacal M; Sun L; Weir-McCall J; Cheema K; Rudd JHF; Mamas M; Erhun F
    BMJ Open; 2022 Jun; 12(6):e059309. PubMed ID: 35710248
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Wait-times Benchmarks for risk-based prioritization in Transcatheter Aortic Valve Implantation: a simulation study.
    Miranda RN; Austin PC; Fremes SE; Mamas MA; Sud MK; Naimark DMJ; Wijeysundera HC
    Eur Heart J Qual Care Clin Outcomes; 2024 Jul; ():. PubMed ID: 39030068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ambulatory TAVR: Early Feasibility Experience During the COVID-19 Pandemic.
    Zouaghi O; Wintzer-Wehekind J; Lienhart Y; Abdellaoui M; Faurie B
    CJC Open; 2020 Nov; 2(6):729-731. PubMed ID: 32864601
    [TBL] [Abstract][Full Text] [Related]  

  • 78. True versus reported waiting times for valvular aortic stenosis surgery.
    Munt BI; Humphries KH; Gao M; Moss RR; Thompson CR
    Can J Cardiol; 2006 May; 22(6):497-502. PubMed ID: 16685314
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Those who do not remember the past are condemned to repeat it.
    Shekar PS; Rinewalt D
    Ann Cardiothorac Surg; 2017 Sep; 6(5):538-540. PubMed ID: 29062751
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modeling of transcatheter aortic valve replacement: Patient specific vs general approaches based on finite element analysis.
    Ovcharenko EA; Klyshnikov KU; Yuzhalin AE; Savrasov GV; Kokov AN; Batranin AV; Ganyukov VI; Kudryavtseva YA
    Comput Biol Med; 2016 Feb; 69():29-36. PubMed ID: 26708469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.